For: | Jiraviriyakul A, Songjang W, Kaewthet P, Tanawatkitichai P, Bayan P, Pongcharoen S. Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns. World J Gastroenterol 2019; 25(29): 3941-3955 [PMID: 31413529 DOI: 10.3748/wjg.v25.i29.3941] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i29/3941.htm |
Number | Citing Articles |
1 |
Yanxia Zhou, Shangqi Zhao, Yanmin Li, Mingkai Yu, Jia Zheng, Qiaoqiao Gong, Chunbao Cao, Jianbing Ding, Xiaotao Zhou. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0558
|
2 |
Kanchana Usuwanthim, Prapakorn Wisitpongpun, Thitiya Luetragoon. Molecular Identification of Phytochemical for Anticancer Treatment. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(6): 651 doi: 10.2174/1871520620666200213110016
|
3 |
Li-ming Zhao, An-da Shi, Yan Yang, Zeng-li Liu, Xiao-Qiang Hu, Li-Zhuang Shu, Yong-chang Tang, Zong-li Zhang. Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1140103
|
4 |
Juan Wang, Emilien Loeuillard, Gregory J. Gores, Sumera I. Ilyas. Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?. Expert Opinion on Therapeutic Targets 2021; 25(10): 835 doi: 10.1080/14728222.2021.2010046
|
5 |
Keisaku Sato, Shannon Glaser, Domenico Alvaro, Fanyin Meng, Heather Francis, Gianfranco Alpini. Cholangiocarcinoma: novel therapeutic targets. Expert Opinion on Therapeutic Targets 2020; 24(4): 345 doi: 10.1080/14728222.2020.1733528
|
6 |
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen, Arunya Jiraviriyakul. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomedical Reports 2021; 15(4) doi: 10.3892/br.2021.1462
|
7 |
Jing-Nan Xue, Yan-Yu Wang, Yun-Chao Wang, Nan Zhang, Long-Hao Zhang, Zheng-Hui Lu, Li-Jin Zhao, Hai-Tao Zhao. Novel cellular therapies for hepatobiliary malignancies. Hepatobiliary & Pancreatic Diseases International 2022; 21(5): 450 doi: 10.1016/j.hbpd.2022.08.014
|
8 |
Ana Laura Esquivel-Campos, Salud Pérez-Gutiérrez, Leonor Sánchez-Pérez, Nimsi Campos-Xolalpa, Julia Pérez-Ramos. Secondary Metabolites - Trends and Reviews. 2022; doi: 10.5772/intechopen.102223
|
9 |
Juan Hao, Xiaoyu Shen, Xiaohong Shao, Chunling Zhu, Kan Lu, Yi Xu, Yiyue Chen, Jibo Liu, Yaqin Ding, Xin Xie, Jian Wu, Quanjun Yang. Honokiol attenuates ductular reaction, regulates of bile acids metabolism, and inhibits inflammatory response in murine cholestatic liver injury model. Arabian Journal of Chemistry 2023; 16(8): 104968 doi: 10.1016/j.arabjc.2023.104968
|
10 |
Haseeb Zubair, Mohammad Aslam Khan, Shashi Anand, Sanjeev Kumar Srivastava, Seema Singh, Ajay Pratap Singh. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy. Seminars in Cancer Biology 2022; 80: 237 doi: 10.1016/j.semcancer.2020.05.009
|
11 |
Luohang Ni, Jianing Xu, Quanpeng Li, Xianxiu Ge, Fei Wang, Xueting Deng, Lin Miao. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer. Cancer Management and Research 2024; : 941 doi: 10.2147/CMAR.S474348
|
12 |
Dong Liu, Lara Rosaline Heij, Zoltan Czigany, Edgar Dahl, Sven Arke Lang, Tom Florian Ulmer, Tom Luedde, Ulf Peter Neumann, Jan Bednarsch. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02340-2
|
13 |
Kai Ma, Zhaowei Sun, Xueliang Li, Jingyun Guo, Qinlei Wang, Mujian Teng. Forkhead box M1 recruits FoxP3+ Treg cells to induce immune escape in hilar cholangiocarcinoma. Immunity, Inflammation and Disease 2022; 10(11) doi: 10.1002/iid3.727
|
14 |
Sul-Ki Kim, Nam-Hun Lee, Chang-Gue Son. A Review of Herbal Resources Inducing Anti-Liver Metastasis Effects in Gastrointestinal Tumors via Modulation of Tumor Microenvironments in Animal Models. Cancers 2023; 15(13): 3415 doi: 10.3390/cancers15133415
|
15 |
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1037945
|
16 |
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, Abdelbaset Mohamed Elasbali, Hassan H. Alhassan, Salem Hussain Alharethi, Asimul Islam, Md. Imtaiyaz Hassan. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics 2023; 41(15): 7511 doi: 10.1080/07391102.2022.2120541
|
17 |
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, Jayanta Samanta, Alexandros Ioannou, Ekaterina Lusina, Rodolfo Sacco, Antonio Facciorusso. Cholangiocarcinoma in the Era of Immunotherapy. Vaccines 2023; 11(6): 1062 doi: 10.3390/vaccines11061062
|